ADMS — ADAMAS PHARMACEUTICALS INC

Ownership history in DCF Advisers, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which DCF Advisers, LLC reported a position in ADAMAS PHARMACEUTICALS INC (ADMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.33% (2021 Q1)
Avg. % of fund
0.17%
First filed
2019 Q4
Last filed
2021 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2021 Q3 UNCHANGED 140,000 — 0% 0.30% $687K —
2021 Q2 REDUCED 140,000 -20,000 -12.5% 0.26% $739K —
2021 Q1 ADDED 160,000 +128,764 +412.2% 0.33% $768K —
2020 Q4 UNCHANGED 31,236 — 0% 0.06% $135K —
2020 Q3 UNCHANGED 31,236 — 0% 0.07% $129K —
2020 Q2 REDUCED 31,236 -4,613 -12.9% 0.04% $80K —
2020 Q1 REDUCED 35,849 -48,026 -57.3% 0.07% $104K —
2019 Q4 INITIATED 83,875 — — 0.20% $318K —
% of Fund (quarterly)

Other funds also holding ADMS

As of 2021 Q3 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 8.75% AIGH Capital Management LLC 3Y 2.67% Worth Venture Partners, LLC 3Y 7Y 1.39% Opaleye Management Inc. 3Y 7Y 1.34% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.8% COOPER CREEK PARTNERS MANAGEMENT LLC 3Y 7Y 0.53% ARMISTICE CAPITAL, LLC 3Y 7Y 0.33% HighVista Strategies LLC 3Y 7Y 0.07% MAI Capital Management 3Y 7Y 0.06% Campbell & CO Investment Adviser LLC 3Y 7Y 0.05%
← Back to DCF Advisers, LLC Holdings